Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation.

Pharmacogenomics J · 2012 · PMC2981689 · PMID 20661272

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

near-significantp = .054so close (0.05 < p ≤ 0.1)

Continuous Abstinence Outcomes Logistic regression models predicting continuous abstinence showed near-significant or significant Genotype × Treatment interactions at EOT (Wald χ 2 = 3.7, p = .054), 6 month (Wald χ 2 = 9.8, p = .002), and 12 month (Wald χ 2 = 4.2, p = .04) follow ups.

also in 2,306 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.